Overview

Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)

Status:
Recruiting
Trial end date:
2023-08-15
Target enrollment:
0
Participant gender:
All
Summary
Suprachoroidal drug delivery is a recent route for managing various ocular conditions. Safety and long term results are still under investigations.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Benha University
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria:

- cases with central macular thickness more than 250 microns measured by optical
coherence tomography due to one of the following conditions:

- Diabetic macular edema

- Vogt-koyanagi Harada disease

- Retinal vein occlusion.

Exclusion Criteria:

- other causes of increased macular thickness as age related macular degeneration and
myopic choroidal new vascularization.

- Cases with confirmed diagnosis of glaucoma.